查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612719

CRISPR 基因编辑市场：按产品、技术、应用和最终用途划分 - 2025-2030 年全球预测

CRISPR Gene Editing Market by Offering (Reagents & Consumables, Services, Software & Systems), Technology (Anti-CRISPR Proteins, CRISPR/Cas13, CRISPR/Cas9), Application, End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年CRISPR基因编辑市值为32.5亿美元，预计到2024年将达到37.7亿美元，复合年增长率为16.81%，到2030年将达到96.6亿美元。

CRISPR基因编辑是一项创新技术，可以精确地修改基因序列，正在彻底改变生物技术和医学。 CRISPR 的应用范围从农业到医学，具有解决遗传性疾病、增强作物抗性并促进生物技术进步的潜力。对 CRISPR 的需求源于其精确定位和编辑遗传密码的能力，这使其对于遗传研究和治疗开发至关重要。 CRISPR 应用包括基因治疗、遗传疾病建模、药物发现和农业基因改造。主要最终用户是参与基因研究和产品开发的学术机构、生技公司和製药公司。

主要市场统计
基准年[2023] 32.5亿美元
预计年份 [2024] 37.7亿美元
预测年份 [2030] 96.6亿美元
复合年增长率（%） 16.81%

根据市场洞察，CRISPR 市场的成长是由遗传学和基因组学研究资金筹措的增加、CRISPR 平台的技术进步以及受诸如此类因素影响的需要创新治疗方法的遗传疾病的患病率上升推动的。商业机会比比皆是，包括扩大 CRISPR 在精准医学中的应用、开发基于 CRISPR 的诊断和合成生物学。公司可以透过投资研究合作、加强知识产权组合以及将应用领域扩展到当前疗法之外来利用这些机会。

然而，由于伦理问题、监管障碍以及与 CRISPR 修饰相关的潜在脱靶效应，市场成长面临限制。专利格局的复杂性也为市场进入者带来了挑战。伦理方面的考虑需要仔细审查和对话，以确保公众接受和监管合规，而正在进行的研究旨在提高基因编辑的特异性并减少意外突变，这就是我的目标。

创新和研究的最佳领域包括提高 CRISPR 的准确性、开发体内应用的递送机制以及探索表观遗传修饰。此外，将 CRISPR 与人工智慧和巨量资料分析相结合可以为研究带来深刻的见解和效率。市场的本质是动态且快速发展的，跨学科合作正在推动进步。为了实现永续成长，公司应专注于解决道德问题和监管途径，同时保持对创新和公民参与的坚定承诺。

市场动态：揭示快速发展的 CRISPR 基因编辑市场的关键市场洞察

供需的动态交互作用正在改变 CRISPR 基因编辑市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 对遗传疾病新疫苗和治疗方法的需求不断增长
    • 增加对生物技术和製药领域的私人和公共投资
    • 在太空探索中采用 CRISPR 基因编辑
  • 市场限制因素
    • CRISPR疗法高成本
  • 市场机会
    • CRISPR 基因编辑的进展与改进
    • CRISPR基因编辑在农业领域的可能性
  • 市场挑战
    • CRISPR 基因编辑的技术挑战与伦理议题

波特五力：开拓 CRISPR 基因编辑市场的策略工具

波特的五力架构是了解 CRISPR 基因编辑市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解 CRISPR 基因编辑市场的外部影响

外部宏观环境因素在塑造 CRISPR 基因编辑市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解 CRISPR 基因编辑市场的竞争格局

对 CRISPR 基因编辑市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵CRISPR基因编辑市场供应商绩效评估

FPNV定位矩阵是评估CRISPR基因编辑市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製 CRISPR 基因编辑市场的成功之路

对于想要加强在全球市场的影响力的公司来说，对 CRISPR 基因编辑市场进行策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对遗传疾病新疫苗和治疗方法的需求增加
      • 增加对生物技术和製药领域的私人和公共投资
      • 在太空探勘中采用 CRISPR 基因编辑
    • 抑制因素
      • CRISPR疗法高成本
    • 机会
      • CRISPR 基因编辑的进展与改进
      • CRISPR基因编辑在农业的潜在应用
    • 任务
      • 与 CRISPR 基因编辑相关的技术挑战和伦理问题
  • 市场区隔分析
    • 技术：CRISPR/Cas13 在涉及 RNA 操作的应用中越来越受欢迎
    • 最终用途：CRISPR 基因编辑在製药和生物技术公司的治疗方法开发和药物发现中日益重要
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 CRISPR 基因编辑市场：透过提供

  • 试剂/耗材
  • 服务
  • 软体及系统

第七章 CRISPR 基因编辑市场：依技术分类

  • 抗CRISPR蛋白
  • 保鲜盒/Cas13
  • 保鲜盒/Cas9
  • CRISPR/Cpf1（Cas12a）

第八章 CRISPR 基因编辑市场：依应用分类

  • 诊断和治疗发展
  • 基因工程
    • 动物基因工程
    • 细胞株工程
    • 植物基因工程

第 9 章 CRISPR 基因编辑市场：依最终用途

  • 学术研究所
  • 製药和生物技术公司

第十章 美洲CRISPR基因编辑市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区CRISPR基因编辑市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲的CRISPR基因编辑市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Synthego 和 SeQure Dx 合作为基于 CRISPR 的疗法开发人员提供全面的脱靶分析服务
    • CRISPR QC 在 A 轮资金筹措中筹集 1000 万美元
    • 新兴企业Tome 以 2.5 亿美元的基因编辑交易收购 Replace TX
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • AstraZeneca PLC
  • Beam Therapeutics Inc.
  • Bio-Rad Laboratories, Inc.
  • Caribou Biosciences, Inc.
  • Cellectis SA
  • CRISPR Therapeutics AG
  • Danaher Corporation
  • Editas Medicine, Inc.
  • F. Hoffmann-La Roche AG
  • GeneCopoeia, Inc.
  • GenScript Biotech Corporation
  • Horizon Discovery Group Ltd. by Revvity, Inc.
  • Inscripta, Inc.
  • Intellia Therapeutics, Inc.
  • Lonza Group Ltd.
  • Mammoth Biosciences, Inc.
  • Merck KGaA
  • New England Biolabs, Inc.
  • OriGene Technologies, Inc.
  • Prime Medicine, Inc.
  • Qiagen NV
  • Sherlock Biosciences, Inc.
  • Thermo Fisher Scientific Inc.
  • ToolGen, Inc.
Product Code: MRR-5C6F41F5AF91

The CRISPR Gene Editing Market was valued at USD 3.25 billion in 2023, expected to reach USD 3.77 billion in 2024, and is projected to grow at a CAGR of 16.81%, to USD 9.66 billion by 2030.

CRISPR gene editing is a transformative technology that allows precise alterations to genetic sequences, which is revolutionizing biotechnology and medicine. The scope of CRISPR extends from agriculture to pharmaceuticals, with the potential to address genetic disorders, enhance crop resistance, and contribute to biotechnological advancements. The necessity of CRISPR arises from its ability to precisely target and edit genetic codes, making it indispensable for genetic research and therapy development. Its applications include gene therapy, genetic disease modeling, drug discovery, and agricultural genetic modification. Key end-users are academic institutions, biotechnology firms, and pharmaceutical companies involved in genetic research and product development.

KEY MARKET STATISTICS
Base Year [2023] USD 3.25 billion
Estimated Year [2024] USD 3.77 billion
Forecast Year [2030] USD 9.66 billion
CAGR (%) 16.81%

Market insights reveal that the CRISPR market growth is influenced by factors such as increased funding for genetic and genomic research, technological advancements in CRISPR platforms, and rising prevalence of genetic disorders that necessitate innovative therapeutic approaches. Opportunities abound in expanding CRISPR applications in precision medicine, developing CRISPR-based diagnostics, and synthetic biology. Companies can capitalize on these opportunities by investing in research collaborations, strengthening intellectual property portfolios, and expanding application areas beyond current therapeutics.

However, market growth faces limitations due to ethical concerns, regulatory hurdles, and potential off-target effects associated with CRISPR modifications. The complexity of patent landscapes also poses challenges to market entrants. Ethical considerations demand careful scrutiny and dialogue to ensure public acceptance and regulatory compliance, while ongoing research aims to improve specificity and reduce unintended mutations in gene editing.

The best areas for innovation and research include enhancing CRISPR accuracy, developing delivery mechanisms for in vivo applications, and exploring epigenetic modifications. Furthermore, integrating CRISPR with artificial intelligence and big data analytics can provide deeper insights and efficiency in research. The nature of the market is dynamic and rapidly evolving, with significant interdisciplinary collaborations driving progress. For sustained growth, businesses should focus on addressing ethical concerns and regulatory pathways while maintaining a strong commitment to technological innovation and public engagement.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving CRISPR Gene Editing Market

The CRISPR Gene Editing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing need for new vaccines and treatments for genetic diseases
    • Increasing private and public investments in biotechnological and pharmaceutical sectors
    • Adoption of CRISPR gene editing in space investigation
  • Market Restraints
    • High cost of CRISPR therapies
  • Market Opportunities
    • Advancements and improvements in CRISPR gene editing
    • Potential use of CRISPR gene editing in the agriculture sector
  • Market Challenges
    • Technical challenges and ethical concerns associated with CRISPR gene editing

Porter's Five Forces: A Strategic Tool for Navigating the CRISPR Gene Editing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the CRISPR Gene Editing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the CRISPR Gene Editing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the CRISPR Gene Editing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the CRISPR Gene Editing Market

A detailed market share analysis in the CRISPR Gene Editing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the CRISPR Gene Editing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the CRISPR Gene Editing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the CRISPR Gene Editing Market

A strategic analysis of the CRISPR Gene Editing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the CRISPR Gene Editing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., AstraZeneca PLC, Beam Therapeutics Inc., Bio-Rad Laboratories, Inc., Caribou Biosciences, Inc., Cellectis S.A., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., F. Hoffmann-La Roche AG, GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Group Ltd. by Revvity, Inc., Inscripta, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Mammoth Biosciences, Inc., Merck KGaA, New England Biolabs, Inc., OriGene Technologies, Inc., Prime Medicine, Inc., Qiagen NV, Sherlock Biosciences, Inc., Thermo Fisher Scientific Inc., and ToolGen, Inc..

Market Segmentation & Coverage

This research report categorizes the CRISPR Gene Editing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Reagents & Consumables, Services, and Software & Systems.
  • Based on Technology, market is studied across Anti-CRISPR Proteins, CRISPR/Cas13, CRISPR/Cas9, and CRISPR/Cpf1 (Cas12a).
  • Based on Application, market is studied across Diagnostics & Therapy Development and Genetic Engineering. The Genetic Engineering is further studied across Animal Genetic Engineering, Cell Line Engineering, and Plant Genetic Engineering.
  • Based on End-use, market is studied across Academic & Research Institutes and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing need for new vaccines and treatments for genetic diseases
      • 5.1.1.2. Increasing private and public investments in biotechnological and pharmaceutical sectors
      • 5.1.1.3. Adoption of CRISPR gene editing in space investigation
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of CRISPR therapies
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements and improvements in CRISPR gene editing
      • 5.1.3.2. Potential use of CRISPR gene editing in the agriculture sector
    • 5.1.4. Challenges
      • 5.1.4.1. Technical challenges and ethical concerns associated with CRISPR gene editing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Increasing preference for CRISPR/Cas13 in application that involves the RNA manipulation
    • 5.2.2. End-use: Growing significance of CRISPR gene editing in pharmaceutical and biotechnology firms for therapeutic development and drug discovery
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. CRISPR Gene Editing Market, by Offering

  • 6.1. Introduction
  • 6.2. Reagents & Consumables
  • 6.3. Services
  • 6.4. Software & Systems

7. CRISPR Gene Editing Market, by Technology

  • 7.1. Introduction
  • 7.2. Anti-CRISPR Proteins
  • 7.3. CRISPR/Cas13
  • 7.4. CRISPR/Cas9
  • 7.5. CRISPR/Cpf1 (Cas12a)

8. CRISPR Gene Editing Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics & Therapy Development
  • 8.3. Genetic Engineering
    • 8.3.1. Animal Genetic Engineering
    • 8.3.2. Cell Line Engineering
    • 8.3.3. Plant Genetic Engineering

9. CRISPR Gene Editing Market, by End-use

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Pharmaceutical & Biotechnology Companies

10. Americas CRISPR Gene Editing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific CRISPR Gene Editing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa CRISPR Gene Editing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Synthego and SeQure Dx Partner to Provide Comprehensive Off-Target Analysis Services for CRISPR-Based Therapeutics Developers
    • 13.3.2. CRISPR QC Raises USD 10 Million in Series A Financing Round
    • 13.3.3. Newcomer Tome Acquires Replace TX in USD 250 Million Gene Editing Deal
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. AstraZeneca PLC
  • 3. Beam Therapeutics Inc.
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Caribou Biosciences, Inc.
  • 6. Cellectis S.A.
  • 7. CRISPR Therapeutics AG
  • 8. Danaher Corporation
  • 9. Editas Medicine, Inc.
  • 10. F. Hoffmann-La Roche AG
  • 11. GeneCopoeia, Inc.
  • 12. GenScript Biotech Corporation
  • 13. Horizon Discovery Group Ltd. by Revvity, Inc.
  • 14. Inscripta, Inc.
  • 15. Intellia Therapeutics, Inc.
  • 16. Lonza Group Ltd.
  • 17. Mammoth Biosciences, Inc.
  • 18. Merck KGaA
  • 19. New England Biolabs, Inc.
  • 20. OriGene Technologies, Inc.
  • 21. Prime Medicine, Inc.
  • 22. Qiagen NV
  • 23. Sherlock Biosciences, Inc.
  • 24. Thermo Fisher Scientific Inc.
  • 25. ToolGen, Inc.

LIST OF FIGURES

  • FIGURE 1. CRISPR GENE EDITING MARKET RESEARCH PROCESS
  • FIGURE 2. CRISPR GENE EDITING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CRISPR GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CRISPR GENE EDITING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CRISPR GENE EDITING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CRISPR GENE EDITING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CRISPR GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CRISPR GENE EDITING MARKET DYNAMICS
  • TABLE 7. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SOFTWARE & SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANTI-CRISPR PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CAS13, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CPF1 (CAS12A), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY DIAGNOSTICS & THERAPY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 235. CRISPR GENE EDITING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 236. CRISPR GENE EDITING MARKET, FPNV POSITIONING MATRIX, 2023